Your session is about to expire
← Back to Search
Intervention plus 10-week feedback booster for Binge Drinking (TIME Trial)
Phase 1 & 2
Waitlist Available
Led By Abby L Braitman, Ph.D.
Research Sponsored by Abby Braitman
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up past 30 days
Awards & highlights
TIME Trial Summary
This trial is testing the best time to send an email with personalized feedback to college students in order to reduce heavy alcohol use.
Eligible Conditions
- Binge Drinking
TIME Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ past 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~past 30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Ethanol
Secondary outcome measures
Alcohol-Related Consequences
TIME Trial Design
6Treatment groups
Active Control
Placebo Group
Group I: Intervention plus 10-week feedback boosterActive Control2 Interventions
Participants navigate through e-checkup to go, the well-established alcohol intervention, then receive the feedback booster email 10 weeks later. It contains a reminder to participate in follow-up surveys, plus personalized feedback based on participant-reported perceived alcohol norms, actual alcohol norms, their own use, and harm reduction strategies.
Group II: Intervention plus repeated feedback boostersActive Control2 Interventions
Participants navigate through e-checkup to go, the well-established alcohol intervention, then receive the multiple feedback booster emails, 2, 6, 10, and 14 weeks later. Each time, the email contains a reminder to participate in follow-up surveys, plus personalized feedback based on participant-reported perceived alcohol norms, actual alcohol norms, their own use, and harm reduction strategies.
Group III: Intervention plus 2-week feedback boosterActive Control2 Interventions
Participants navigate through e-checkup to go, the well-established alcohol intervention, then receive the feedback booster email 2 weeks later. It contains a reminder to participate in follow-up surveys, plus personalized feedback based on participant-reported perceived alcohol norms, actual alcohol norms, their own use, and harm reduction strategies.
Group IV: Intervention plus 6-week feedback boosterActive Control2 Interventions
Participants navigate through e-checkup to go, the well-established alcohol intervention, then receive the feedback booster email 6 weeks later. It contains a reminder to participate in follow-up surveys, plus personalized feedback based on participant-reported perceived alcohol norms, actual alcohol norms, their own use, and harm reduction strategies.
Group V: Intervention plus 14-week feedback boosterActive Control2 Interventions
Participants navigate through e-checkup to go, the well-established alcohol intervention, then receive the feedback booster email 14 weeks later. It contains a reminder to participate in follow-up surveys, plus personalized feedback based on participant-reported perceived alcohol norms, actual alcohol norms, their own use, and harm reduction strategies.
Group VI: Intervention-only ControlPlacebo Group1 Intervention
Participants navigate through e-checkup to go, the well-established alcohol intervention. Any follow-up emails sent to them later contain only a reminder to participate in follow-up surveys.
Find a Location
Who is running the clinical trial?
Abby BraitmanLead Sponsor
4 Previous Clinical Trials
1,564 Total Patients Enrolled
National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
799 Previous Clinical Trials
1,362,316 Total Patients Enrolled
12 Trials studying Binge Drinking
7,190 Patients Enrolled for Binge Drinking
Abby L Braitman, Ph.D.Principal InvestigatorOld Dominion University
4 Previous Clinical Trials
1,564 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger